Does PEGASPARGASE Cause Intracardiac thrombus? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Intracardiac thrombus have been filed in association with PEGASPARGASE (ONCASPAR). This represents 0.6% of all adverse event reports for PEGASPARGASE.
71
Reports of Intracardiac thrombus with PEGASPARGASE
0.6%
of all PEGASPARGASE reports
54
Deaths
16
Hospitalizations
How Dangerous Is Intracardiac thrombus From PEGASPARGASE?
Of the 71 reports, 54 (76.1%) resulted in death, 16 (22.5%) required hospitalization, and 2 (2.8%) were considered life-threatening.
Is Intracardiac thrombus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGASPARGASE. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does PEGASPARGASE Cause?
Febrile neutropenia (1,589)
Pyrexia (706)
Febrile bone marrow aplasia (668)
Sepsis (548)
Vomiting (530)
Neutropenia (521)
Abdominal pain (469)
Hypertriglyceridaemia (399)
Hypotension (388)
Thrombocytopenia (382)
What Other Drugs Cause Intracardiac thrombus?
APIXABAN (179)
RIVAROXABAN (143)
YASMIN (115)
YAZ (115)
ADALIMUMAB (85)
METHOTREXATE (82)
VINCRISTINE (78)
DEXAMETHASONE (74)
SACUBITRIL\VALSARTAN (73)
CYCLOPHOSPHAMIDE (71)
Which PEGASPARGASE Alternatives Have Lower Intracardiac thrombus Risk?
PEGASPARGASE vs PEGASYS
PEGASPARGASE vs PEGCETACOPLAN
PEGASPARGASE vs PEGFILGRASTIM
PEGASPARGASE vs PEGFILGRASTIM-APGF
PEGASPARGASE vs PEGFILGRASTIM-BMEZ